Elucidation of the antistaphylococcal action of lactoferrin and lysozyme

Journal of Medical Microbiology

Volumn 48, Issue 9, 1999, Pages 867-871

  Leitch, E C ^a   Willcox, M D P ^a  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

LACTOFERRIN; LIPOTEICHOIC ACID; LYSOZYME; TEAR PROTEIN;

ARTICLE; AUTOLYSIS; BINDING SITE; NONHUMAN; PRIORITY JOURNAL; STAPHYLOCOCCUS EPIDERMIDIS;

EID: 0032846808     PISSN: 00222615     EISSN: None     Source Type: Journal    
DOI: 10.1099/00222615-48-9-867     Document Type: Article

References (23)

1. 1. Stryer L (ed) Mechanisms of enzyme action. In: Biochemistry, 3rd edn. New York, WH Freeman and Co. 1988: 201-211.
2. 2. Fleming A. On a remarkable bacteriolytic element found in tissues and secretions. Proc R Soc B 1922; 93: 306-317.
3. 3. Selsted ME, Martinez RJ. Lysozyme: primary bactericidin in human plasma serum active against Bacillus subtilis. Infect Immun 1978; 20: 782-791.
4. 4. Arnold RR, Brewer M, Gauthier JJ. Bactericidal activity of human lactoferrin: sensitivity of a variety of microorganisms. Infect Immun 1980; 28: 893-898.
5. 5. Arnold RR, Russell JE, Champion WJ, Brewer M, Gauthier JJ. Bactericidal activity of human lactoferrin: differentiation from the stasis of iron deprivation. Infect Immun 1982; 35: 792-799.
6. 6. Ellison RT, Giehl TJ, LaForce FM. Damage of the outer membrane of enteric Gram-negative bacteria by lactoferrin and transferrin. Infect Immun 1988; 56: 2774-2781.
7. 7. Ellison RT, Giehl TJ. Killing of Gram-negative bacteria by lactoferrin and lysozyme. J Clin Invest 1991; 88: 1080-1091.
8. 8. Leitch EC, Willcox MDP. Synergic antistaphylococcal properties of lactoferrin and lysozyme. J Med Microbiol 1998; 47: 837-842.
9. 9. Naidu AS, Arnold RR. Lactoferrin interaction with Salmonellac potentiates antibiotic susceptibility in vitro. Diagn Microbiol Infect Dis 1994; 20: 69-75.
10. 10. Leitch EC, Willcox MDP. Lactoferrin increases the susceptibility of S. epidermidis biofilms to lysozyme and vancomycin. Curr Eye Res 1998; 18 (in press).
11. 11. Leitch EC, Willcox MDP. Interactions between the constitutive host defences of tears and Staphylococcus epidermidis. Aust NZ J Ophthalmol 1997; 25 Suppl 1: 20-22.
12. 12. Fischer W, Rosel P, Koch HU. Effect of alanine ester substitution and other structural features of lipoteichoic acids on their inhibitory activity against autolysins of Staphylococcus aureus. J Bacteriol 1981; 146: 467-475.
13. 13. Morse SI. Biological attributes of staphylococcal cell walls. Ann NY Acad Sci 1965; 128; 191-213.
14. 14. Johansen C. Enzyme and cationic peptides with antibacterial activity. PhD thesis. 1997.
15. 15. Bellamy WR, Wakabayashi H, Takase M, Kawase K, Shimamura S, Tomita M. Role of cell-binding in the antibacterial mechanism of lactoferricin B. J Appl Bacteriol 1993; 75: 478-484.
16. 16. Bellamy W, Takase M, Yamauchi K, Wakabayashi H, Kawase K, Tomita M. Identification of the bactericidal domain of lactoferrin. Biochim Biophys Acta 1992; 1121: 130-136.
17. 17. Shafer WM, Onunka VC. Mechanism of staphylococcal resistance to non-oxidative antimicrobial action of neutrophils: importance of pH and ionic strength in determining the bactericidal action of Cathepsin G. J Gen Microbiol 1989; 135: 825-830.
18. 18. Bierbaum G, Sahl H-G. Influence of cationic peptides on the activity of the autolytic endo-β-N-acetylglucosaminidase of Staphylococcus simulans 22. FEMS Microbiol Lett 1988; 58: 223-228.
19. 19. Ruhland GJ, Fiedler F. Occurrence and structure of lipoteichoic acids in the genus Staphylococcus. Arch Microbiol 1990; 154: 375-379.
20. 20. Fischer W. Lipoteichoic acid and lipids in the membrane of Staphylococcus aureus. Med Microbiol Immunol 1994; 183: 61-76.
21. 21. Wecke J, Perego M, Fischer W. D-alanine deprivation of Bacillus subtilis teichoic acids is without effect on cell growth and morphology but affects the autolytic activity. Microb Drug Resist 1996; 2: 123-129.
22. 22. Ofek I, Simpson WA, Beachey EH. Formation of molecular complexes between a structurally defined M protein and acylated or deacylated lipoteichoic acid of Streptococcus pyogenes. J Bacteriol 1982; 149: 426-433.
23. 23. Sela MN, Lahav M, Ginsburg I. Effect of leukocyte hydrolases on bacteria. IX. The release of lipoteichoic acid from Group A streptococci and from Strep. mutans by leukocyte extracts and by lysozyme: relation to tissue damage in inflammatory sites. Inflammation 1977; 2: 151-164.